N/a
-Jul 14 2020: Announces Investigator-Sponsored Trial of Fostamatinib in Patients with COVID-19 Pneumonia
-SPY pattern: Runner
-Intraday pattern: Consolidation
-Other notes: Also notes of Bowl and Bull flag intraday price action
Strategy: First test long of 4.15 level
Confluence: N/a
Strike Zone: 4.15 - 4.10
Sizing (lots + emergency): 1+1
Risk (stop / Rs): 3.99
It was really heavy in the high teens so I didn't want to risk it, sold due to heavy tape, still small wallet padder
Execution detail:
Date/time | Symbol | Side | Price | Position |
---|---|---|---|---|
2020-07-14 13:52:57 | RIGL | buy | $4.130 | long |
2020-07-14 13:52:57 | RIGL | buy | $4.130 | long |
2020-07-14 13:53:31 | RIGL | sell | $4.160 | long |
2020-07-14 13:55:11 | RIGL | sell | $4.160 | long |
2020-07-14 13:55:11 | RIGL | sell | $4.165 | 0 |
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!